Company

Macrophage Therapeutics, Inc.

Biotechnology Research Englewood Cliffs, New Jersey, United States 6 employees

Employees: 6

macrophagetx.com LinkedIn

Macrophage Therapeutics, Inc. Overview

Headquarters: Englewood Cliffs, New Jersey, United States
Website: macrophagetx.com
Industry: Biotechnology Research
Employees: 6
Founded: 2015
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Representative jobs

About Macrophage Therapeutics, Inc.

Macrophage Therapeutics (MT) is developing novel targeted anti-inflammatory and immuno-oncology therapeutics based on its proprietary Activated Macrophage targeting platform. MT is leveraging its unique CD206 receptor-based delivery system to deliver proven therapeutics in a more precise and targeted fashion. With binding affinities 10,000X today’s best antibodies MT’s approach eliminates off-target toxicity and increases the efficacy of proven therapeutic agents. MT’s CD206 targeting platform is already clinically established and being used in an FDA/EMEA approved radiopharmaceutical.